The News Feed


Antibiotic Resistance Remains Prevalent in Ocular Staphylococcal Infections

Newest ARMOR study data helps inform clinicians when choosing a therapy to pursue in affected patients.
May 11, 2022

Hearing Loss a Possible Complication of Thyroid Eye Disease Drug

A small case series of teprotumumab-treated patients experienced auditory changes and other otologic symptoms.
March 8, 2022

Teprotumumab Promising as Treatment For Proptosis, Diplopia

Compared with placebo and methylprednisolone, the drug was associated with greater symptomatic improvement.
February 25, 2022

Oral CAIs More Safe Than Many Believe

The risk of adverse events was comparable to that of topical formulations, study finds.
February 1, 2022

First Presbyopia Eye Drop Approved

The pilocarpine agent improves near and intermediate acuity, according to manufacturer Allergan.
October 29, 2021

TNS Safe Treatment for Ocular Pain

Study suggests three- to six-month use of a trigeminal neurostimulator decreased eye pain, light and wind sensitivity, and burning sensations.
June 1, 2021

2021 ARMOR Results Find Staph Resistance Still Problematic

However, S. aureus had a significant decrease in methicillin resistance.
May 4, 2021

Economic Burden Worsens for Glaucoma Patients

Studies found additional IOP-lowering drops led to higher costs with only short-term benefits and observed a spike in brand name med prices.
March 24, 2021

Atropine Penetration Minimally Affected by Preservatives

Stability and safety of the drug are better predictors of successful outcomes.
February 16, 2021

Glaucoma Patients More Likely to Respond to Steroids

However, longer axial length and a heavier medication burden may decrease the effectiveness of therapy post-op.
February 9, 2021